Purpose of this Study
We are doing this research to learn more about whether taking a blood thinner, along with medications that prevent blood clots, improve outcomes in patients who develop atrial fibrillation (irregular heartbeat) after coronary artery bypass grafting surgery.
Who Can Participate?
Eligibility
Adults who developed atrial fibrillation after coronary artery bypass grafting surgery.
What is Involved?
If you agree to be in this study, you will:
- Be randomly assigned (a fair 50/50 chance) to get the study drug or aspirin for 90 days
- Have an in-person study visit at 90 days
- Have blood tests
- Fill out questionnaires
- Have an ECGs (looks at your heart)
- Have phone up to 4 phone calls with a member of the study team
If you do not want to be part of the randomized study you may participate in a registry collecting data from your hospitalization for atrial fibrillation.
- Be randomly assigned (a fair 50/50 chance) to get the study drug or aspirin for 90 days
- Have an in-person study visit at 90 days
- Have blood tests
- Fill out questionnaires
- Have an ECGs (looks at your heart)
- Have phone up to 4 phone calls with a member of the study team
If you do not want to be part of the randomized study you may participate in a registry collecting data from your hospitalization for atrial fibrillation.
Study Details
Full Title
Anticoagulation for the New-Onset Post-Operative Atrial Fibrillation after CABG
Principal Investigator
Brittany
Zwischenberger
Protocol Number
PRO00103761
NCT ID
NCT04045665
Phase
N/A
Enrollment Status
OPEN TO ACCRUAL